Chao Huang

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Topic:
    Investigator initiated trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2028
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    PI of company sposored trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2028
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novocure
    Topic:
    PI of company sponsored tria
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2028
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    pfizer
    Topic:
    PI of company sponsored trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2028
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Epicentrix
    Topic:
    PI of company sponsored trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Henlius
    Topic:
    PI of company sponsored trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Summit therapeutics
    Topic:
    PI of company sponsored trial
    Date added:
    03/08/2025
    Date updated:
    03/08/2025
    Relationship end date:
    03/31/2028
Return to Kansas City Precision Oncology Conference